Arbro Pharmaceuticals launches Vkap-D3 for the treatment of Vitamin- D Deficiency in India
New Delhi [India], August 5 (ANI/SRV): Arbro Pharmaceuticals Pvt Ltd, a leading Research-Driven Pharmaceutical Manufacturing Organization with major expertise in Oral Solid Dose and liquid-filled hard gel capsules, has successfully launched Vkap-D3, a plant-based capsule.
ANI
Aug 05, 2022 16:36 IST
New Delhi [India], August 5 (ANI/SRV): Arbro Pharmaceuticals Pvt Ltd, a leading Research-Driven Pharmaceutical Manufacturing Organization with major expertise in Oral Solid Dose and liquid-filled hard gel capsules, has successfully launched Vkap-D3, a plant-based capsule.
Vkap-D3 contains Vitamin D3 60,000 IU in a unique liquid-filled hard vegetarian capsule shell - made of HPMC (having plant-based origin) to help treat Vitamin D deficiency.
Vkap-D3 is presented in a vegetarian capsules shell which will lead to better acceptance with the large vegetarian population of the country who are averse to consuming gelatin capsules.
There are various advantages to using HPMC capsules: it is chemically and thermally more stable compared to soft gelatin, making it more suitable for the harsh and varied temperature conditions during distribution and storage in India.
Vkap D3 is an oral, Vitamin D (60,000 IU weekly) regimen that rapidly normalizes 25 (OH) D levels and ensures better symptomatic relief than a daily dosage of 1000 IU for the same duration.
Studies indicate that 76 per cent of Indians suffer from Vitamin D deficiency and insufficiency.
The sedentary lifestyle, less exposure to sunlight, pollution, lack of proper nutrition and consumption of ultra-processed foods is leading to Vitamin D deficiency. Vkap D3 will be effective in dealing with Vitamin D deficiency in people. Vitamin D facilitates in maintaining the functions of our body's nerves and muscles, cardiovascular, respiratory, and immune system and improves the overall quality of life.
Commenting on the development Executive Director of ARBRO and Managing Director of Auriga Research Pvt Ltd, Dr Saurabh Arora said, "There is a very high prevalence of Vitamin D deficiency in India with some studies reporting as high as 90 per cent of the population having Vitamin D deficiency. VKap D3 has been developed to provide a bioavailable and stable formulation using unique vegetarian capsule shells so that this essential therapy can reach an even larger population".
Vitamin D3 medication is commonly recommended for people at risk for vitamin D deficiency. Low vitamin D levels cause depression, fatigue, and muscle weakness. Over time, vitamin D deficiency can lead to weak bones, rickets in children, and osteoporosis in adults.
To know more contact
Manish Ranjan (Vice President - Corporate) |
Email-arbrolab@arbropharma.com | +91 -11-45854585 |+91- 8588851888|
Website: www.arbropharma.com
This story is provided by SRV. ANI will not be responsible in any way for the content of this article. (ANI/SRV)
Tags:
Get the App
